UBS MSCI Switzerland 20/35 UCITS ETF (LON:0A5N)
London
· Delayed Price · Currency is GBP · Price in USD | Assets | 79.20M |
| Expense Ratio | 0.23% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +1.11% |
| Volume | 2,313 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Low | 10.55 |
| 52-Week High | 12.17 |
| Beta | n/a |
| Holdings | 45 |
| Inception Date | Jun 24, 2020 |
About 0A5N
UBS ETF SICAV - MSCI Switzerland 20/35 UCITS ETF is an exchange traded fund launched by UBS Fund Management (Luxembourg) S.A. It is co-managed by UBS Asset Management (UK) Limited and UBS Asset Management. The fund invests in the public equity markets of Switzerland. It invests directly and through derivatives such as forwards in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Switzerland 20/35 Index, by investing in the stocks as per their weightings in the index. UBS ETF SICAV - MSCI Switzerland 20/35 UCITS ETF was formed on October 31, 2013 and is domiciled in Luxembourg.
Performance
0A5N had a total return of 1.11% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.73%.
Top 10 Holdings
72.54% of assets| Name | Symbol | Weight |
|---|---|---|
| Nestlé S.A. | NESN | 16.29% |
| Roche Holding AG | ROG | 12.92% |
| Novartis AG | NOVN | 12.80% |
| Zurich Insurance Group AG | ZURN | 5.83% |
| UBS Group AG | UBSG | 5.49% |
| Compagnie Financière Richemont SA | CFR | 5.26% |
| ABB Ltd | ABBN | 4.76% |
| Holcim AG | HOLN | 3.34% |
| Swiss Re AG | SREN | 3.04% |
| Lonza Group AG | LONN | 2.81% |